TECSOTRA Trademark

Trademark Overview

On Friday, October 31, 2008, a trademark application was filed for TECSOTRA with the United States Patent and Trademark Office. The USPTO has given the TECSOTRA trademark a serial number of 79061523. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, October 31, 2018. This trademark is owned by Novartis AG. The TECSOTRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; pharmaceutical preparations for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology, and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes; anti-infective preparations, antiviral preparations, antibiotics, and antifungal preparations
tecsotra

General Information

Serial Number79061523
Word MarkTECSOTRA
Filing DateFriday, October 31, 2008
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, October 31, 2018
Registration Number3635618
Registration DateTuesday, June 9, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 24, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; pharmaceutical preparations for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology, and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes; anti-infective preparations, antiviral preparations, antibiotics, and antifungal preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateTuesday, October 6, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH

Trademark Events

Event DateEvent Description
Tuesday, May 28, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Tuesday, May 28, 2019DEATH OF INTERNATIONAL REGISTRATION
Friday, November 18, 2016NOTIFICATION PROCESSED BY IB
Friday, October 23, 2015NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, October 23, 2015DEATH OF INTERNATIONAL REGISTRATION
Monday, April 15, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, April 13, 2013NEW REPRESENTATIVE AT IB RECEIVED
Saturday, February 23, 2013CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, September 22, 2009FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, September 22, 2009FINAL DISPOSITION PROCESSED
Thursday, September 10, 2009FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, June 26, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 26, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 9, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, March 24, 2009PUBLISHED FOR OPPOSITION
Wednesday, March 4, 2009NOTICE OF PUBLICATION
Tuesday, February 17, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, February 14, 2009ASSIGNED TO LIE
Friday, February 6, 2009REFUSAL PROCESSED BY IB
Thursday, February 5, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 5, 2009EXAMINER'S AMENDMENT ENTERED
Thursday, February 5, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 5, 2009EXAMINERS AMENDMENT E-MAILED
Thursday, February 5, 2009EXAMINERS AMENDMENT -WRITTEN
Monday, February 2, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 2, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 5, 2009NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, January 5, 2009REFUSAL PROCESSED BY MPU
Thursday, January 1, 2009NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, December 31, 2008NON-FINAL ACTION WRITTEN
Wednesday, December 31, 2008ASSIGNED TO EXAMINER
Friday, December 12, 2008APPLICATION FILING RECEIPT MAILED
Monday, December 8, 2008NEW APPLICATION ENTERED IN TRAM
Friday, December 5, 2008LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Friday, December 5, 2008SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

tecsotra system preparations treatment disorders pharmaceutical prevention diseases ocular transplantation bacteria